We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Applied Biosystems and Agilent Technologies Reach Settlement Agreement Regarding Real-Time PCR Thermal Cyclers
News

Applied Biosystems and Agilent Technologies Reach Settlement Agreement Regarding Real-Time PCR Thermal Cyclers

Applied Biosystems and Agilent Technologies Reach Settlement Agreement Regarding Real-Time PCR Thermal Cyclers
News

Applied Biosystems and Agilent Technologies Reach Settlement Agreement Regarding Real-Time PCR Thermal Cyclers

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Applied Biosystems and Agilent Technologies Reach Settlement Agreement Regarding Real-Time PCR Thermal Cyclers"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Applied Biosystems, an Applera Corporation business, and Agilent Technologies have entered into a settlement agreement resolving patent infringement lawsuits originally filed by Applera against Stratagene (acquired by Agilent in 2007), alleging infringement of Applera’s Real-Time thermal cycler instrument patents.

The lawsuits resulted in injunctions in Germany and the Netherlands and were pending in the U.S. and France.

In connection with the settlement, Agilent has entered into an agreement with Applera to license certain Applera technology relating to Agilent’s Real-Time thermal cycler instrument business in research-related fields and excluding the field of human in vitro diagnostics.

The two companies also announced that Agilent has entered into another agreement with Applera to license certain Applera technology relating to Agilent’s PCR and Real-Time enzymes and kits.

Financial terms of the settlement and related license agreements were not disclosed.

These agreements fully resolve all pending disputes between Applera and Stratagene.

 

 

http://www.appliedbiosystems.com

Advertisement